Title: Full Text of HB3605
Official Title: 
Number of Sections: 1
Source: versions - Introduced
Media Type: text/html

================================================================================

Section 1:
Full Text of HB3605 ILGA.GOV HB3605 - 104th General Assembly 104TH GENERAL ASSEMBLY State of Illinois 2025 and 2026HB3605 Introduced 2/18/2025, by Rep. Camille Y. Lilly SYNOPSIS AS INTRODUCED: 215 ILCS 5/356u.10    Amends the Illinois Insurance Code. Makes changes to defined terms. Provides that a group policy of accident and health insurance or managed care plan that is amended, delivered, issued, or renewed after January 1, 2026 shall provide coverage for evidence-based cancer imaging for individuals with an increased risk of cancer as recommended by the current National Comprehensive Cancer Network clinical practice guidelines. Provides that this coverage shall be provided without cost-sharing, and the requirements of the Act shall not apply to the extent that providing coverage would disqualify a high-deductible health plan from eligibility for a health savings account.LRB104 09298 BAB 19356 b  A BILL FOR HB3605LRB104 09298 BAB 19356 b1    AN ACT concerning regulation. 2    Be it enacted by the People of the State of Illinois, 3represented in the General Assembly: 4    Section 5. The Illinois Insurance Code is amended by 5changing Section 356u.10 as follows: 6    (215 ILCS 5/356u.10)7    Sec. 356u.10. Genetic testing and evidence-based 8screenings for an inherited gene mutation.9    (a) As used in In this Section: , 10    "Genetic genetic testing for an inherited mutation" means 11germline multi-gene testing for an inherited mutation 12associated with an increased risk of cancer in accordance with 13evidence-based, clinical practice guidelines.14    "Cost-sharing requirements" means a deductible, 15coinsurance, copayment, or any similar out-of-pocket expense.16    "Evidence-based cancer imaging" means evidence-based 17cancer imaging modalities in accordance with the most recent 18version of the National Comprehensive Cancer Network clinical 19practice guidelines. 20    (b) A group policy of accident and health insurance or 21managed care plan that is amended, delivered, issued, or 22renewed after January 1, 2026 shall provide coverage for 23clinical genetic testing for an inherited gene mutation for   HB3605- 2 -LRB104 09298 BAB 19356 b1individuals with a personal or family history of cancer, as 2recommended by a health care professional in accordance with 3current evidence-based clinical practice guidelines, 4including, but not limited to, the current version of the 5National Comprehensive Cancer Network clinical practice 6guidelines, and evidence-based cancer imaging for individuals 7with an increased risk of cancer as recommended by the current 8National Comprehensive Cancer Network clinical practice 9guidelines. This coverage shall be provided without 10cost-sharing. The coverage shall limit the total amount that a 11covered person is required to pay for a clinical genetic test 12under this subsection to an amount not to exceed $50, except 13for services for which cost sharing is prohibited under 42 14U.S.C. 300gg-13. This subsection (b) shall not apply to 15coverage of genetic testing to the extent that providing such 16coverage would disqualify a high-deductible health plan from 17eligibility for a health savings account pursuant to Section 18223 of the Internal Revenue Code.19    (c) (Blank). For individuals with a genetic test that is 20positive for an inherited mutation associated with an 21increased risk of cancer, coverage required under this Section 22shall include any evidence-based screenings, as recommended by 23a health care professional in accordance with current 24evidence-based clinical practice guidelines, to the extent 25that the management recommendation is not already covered by 26the policy, except that coverage for evidence-based screenings   HB3605- 3 -LRB104 09298 BAB 19356 b1under this subsection (c) may be subject to a deductible, 2coinsurance, or other cost-sharing limitation so long as the 3limitation is not greater than that required for other related 4cancer risk management benefits covered under the policy. In 5this subsection, "evidence-based cancer screenings" means 6medically recommended evidence-based screening modalities in 7accordance with current clinical practice guidelines.8(Source: P.A. 103-914, eff. 1-1-25.)


================================================================================

Raw Text:
Full Text of HB3605 ILGA.GOV HB3605 - 104th General Assembly 104TH GENERAL ASSEMBLY State of Illinois 2025 and 2026HB3605 Introduced 2/18/2025, by Rep. Camille Y. Lilly SYNOPSIS AS INTRODUCED: 215 ILCS 5/356u.10    Amends the Illinois Insurance Code. Makes changes to defined terms. Provides that a group policy of accident and health insurance or managed care plan that is amended, delivered, issued, or renewed after January 1, 2026 shall provide coverage for evidence-based cancer imaging for individuals with an increased risk of cancer as recommended by the current National Comprehensive Cancer Network clinical practice guidelines. Provides that this coverage shall be provided without cost-sharing, and the requirements of the Act shall not apply to the extent that providing coverage would disqualify a high-deductible health plan from eligibility for a health savings account.LRB104 09298 BAB 19356 b  A BILL FOR HB3605LRB104 09298 BAB 19356 b1    AN ACT concerning regulation. 2    Be it enacted by the People of the State of Illinois, 3represented in the General Assembly: 4    Section 5. The Illinois Insurance Code is amended by 5changing Section 356u.10 as follows: 6    (215 ILCS 5/356u.10)7    Sec. 356u.10. Genetic testing and evidence-based 8screenings for an inherited gene mutation.9    (a) As used in In this Section: , 10    "Genetic genetic testing for an inherited mutation" means 11germline multi-gene testing for an inherited mutation 12associated with an increased risk of cancer in accordance with 13evidence-based, clinical practice guidelines.14    "Cost-sharing requirements" means a deductible, 15coinsurance, copayment, or any similar out-of-pocket expense.16    "Evidence-based cancer imaging" means evidence-based 17cancer imaging modalities in accordance with the most recent 18version of the National Comprehensive Cancer Network clinical 19practice guidelines. 20    (b) A group policy of accident and health insurance or 21managed care plan that is amended, delivered, issued, or 22renewed after January 1, 2026 shall provide coverage for 23clinical genetic testing for an inherited gene mutation for   HB3605- 2 -LRB104 09298 BAB 19356 b1individuals with a personal or family history of cancer, as 2recommended by a health care professional in accordance with 3current evidence-based clinical practice guidelines, 4including, but not limited to, the current version of the 5National Comprehensive Cancer Network clinical practice 6guidelines, and evidence-based cancer imaging for individuals 7with an increased risk of cancer as recommended by the current 8National Comprehensive Cancer Network clinical practice 9guidelines. This coverage shall be provided without 10cost-sharing. The coverage shall limit the total amount that a 11covered person is required to pay for a clinical genetic test 12under this subsection to an amount not to exceed $50, except 13for services for which cost sharing is prohibited under 42 14U.S.C. 300gg-13. This subsection (b) shall not apply to 15coverage of genetic testing to the extent that providing such 16coverage would disqualify a high-deductible health plan from 17eligibility for a health savings account pursuant to Section 18223 of the Internal Revenue Code.19    (c) (Blank). For individuals with a genetic test that is 20positive for an inherited mutation associated with an 21increased risk of cancer, coverage required under this Section 22shall include any evidence-based screenings, as recommended by 23a health care professional in accordance with current 24evidence-based clinical practice guidelines, to the extent 25that the management recommendation is not already covered by 26the policy, except that coverage for evidence-based screenings   HB3605- 3 -LRB104 09298 BAB 19356 b1under this subsection (c) may be subject to a deductible, 2coinsurance, or other cost-sharing limitation so long as the 3limitation is not greater than that required for other related 4cancer risk management benefits covered under the policy. In 5this subsection, "evidence-based cancer screenings" means 6medically recommended evidence-based screening modalities in 7accordance with current clinical practice guidelines.8(Source: P.A. 103-914, eff. 1-1-25.)